Tag: Medicine
-
General Internal Medicine Fellow Inducted into Landsberg Society
Natalie Cameron, MD, a general internal medicine research fellow in the Department of Medicine, will be inducted into the Lewis Landsberg Society, which connects former residents and fellows from Northwestern University Feinberg School of Medicine.
-
Drug Demonstrates Poor Efficacy in Advanced Bladder Cancer
An FDA-approved monoclonal antibody drug used to treat advanced bladder cancer demonstrated poor efficacy in a recent clinical trial.
-
Gastrointestinal Surgical Technique Linked to Lower Recurrence of Cancer
Endoscopic submucosal dissection can be performed as safely and effectively as alternative techniques and is associated with lower cancer recurrence, according to a recent study.
-
Identifying Molecular Mechanisms Within the Nuclear Lamina
Northwestern Medicine investigators discovered that nuclear surface proteins called nuclear lamin isoforms regulate nuclear pore complexes, shedding light on the role molecular mechanisms play in genetic mutations behind many rare diseases.
-
Suppressive Immune Cells Combat Chronic Inflammation
A team of Northwestern Medicine scientists have discovered that a specific type of immune cell is necessary for the suppression of chronic inflammation, revealing a potential therapeutic target for patients with rheumatoid arthritis.
-
Evaluating Perioperative Chemotherapy for Pancreatic Cancer
Perioperative chemotherapy treatment did not improve overall survival for patients with resectable pancreatic cancer, according to a recent Northwestern Medicine clinical trial.
-
Northwestern Investigators Explore COVID-19 Treatments
Working with large, multicenter teams, Northwestern clinician-scientists have examined treatments for blood clotting in critically ill patients with COVID-19, and explored therapies that could reduce disease progression and hospitalization.
-
Multi-faceted Therapeutic Target for Metabolic Syndrome Discovered
Northwestern Medicine investigators have discovered a potential multi-faceted therapeutic target for preventing and treating the metabolic syndrome, according to a recent study.
-
Cardio-Kidney Trials Present Obstacles
A new class of drugs shows benefit for both cardiovascular and kidney conditions, but scientists should be cautious in designing trials that include both cardiovascular and kidney outcomes in the same analysis, according to a Northwestern Medicine review article.
-
Feinberg Investigators Explore COVID-19 Treatments and Impact
Feinberg investigators continue to investigate new treatments for COVID-19 and share insights on combating misinformation and mitigating the disease’s spread.
